Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine and a related shot by the Serum Institute of India for use in this country with the first doses expected to arrive soon.
Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Their focus is on developing medicines that can provide strong clinical performance, measurable patient benefit and economic value, particularly in areas where there is significant need, such as hepatitis C, neuroscience, immunology, oncology, chronic kidney disease and women’s health.
AbbVie combines advanced science, global capabilities and passion to provide innovative therapies that help people manage some of the most serious health conditions.
Contact Info8401 Trans-Canada Highway Saint-Laurent, H4S 1Z1 QC Canada
P: 1 204 293 4358